NCT03619941

Continuous Tart Cherry Juice Supplementation With Metabolic Syndrome Participants

Effects of 7-day Continuous Montmorency Tart Cherry Juice Supplementation in Metabolic Syndrome Participants: a Pilot Study

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 12 (actual)
• Sponsor: University of Hertfordshire · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

The present study examined the effect of Montmorency tart cherry juice on functional and blood-based cardio-metabolic markers in humans with Metabolic Syndrome. Participants consumed Montmorency tart cherry juice or a placebo beverage continuously for 7 days in a randomised, crossover trial. Outcome variables were measured immediately prior to supplementation and post-supplementation. Furthermore, on the 7th day of supplementation outcome variables were measured pre- and up to 5 hours post-bolus. It was hypothesised that Montmorency tart cherry juice would improve cardio-metabolic markers, particularly fasting insulin and systolic blood pressure. Furthermore, the study aimed to identify the mechanism of action for any effects of Montmorency tart cherry juice on blood pressure.

Conditions

• Metabolic Syndrome
• Insulin Resistance
• Hypertension

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Montmorency Tart Cherry Juice	100% natural, tart Montmorency cherry concentrate (30mL) diluted with 100mL water. Concentrate contains no sweeteners, preservatives, flavourings or added sugar.
DIETARY_SUPPLEMENT	Placebo	Placebo drink attempted to match for total energy content, macronutrient content, appearance and taste of Montmorency tart cherry juice.

Timeline

• Start date: 2018-05-15
• Primary completion: 2018-09-20
• Completion: 2018-09-29
• First posted: 2018-08-08
• Last updated: 2019-02-19

Locations

1 site across 1 country: United Kingdom